A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice.
Wiedemann GM, Jacobi SJ, Chaloupka M, Krächan A, Hamm S, Strobl S, Baumgartner R, Rothenfusser S, Duewell P, Endres S, Kobold S.
Wiedemann GM, et al. Among authors: endres s.
Oncoimmunology. 2016 May 31;5(7):e1189051. doi: 10.1080/2162402X.2016.1189051. eCollection 2016 Jul.
Oncoimmunology. 2016.
PMID: 27622045
Free PMC article.